Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E20.80 EPS (ttm)0.41 Insider Own0.10% Shs Outstand50.78M Perf Week-0.12%
Market Cap433.15M Forward P/E12.19 EPS next Y0.70 Insider Trans-0.35% Shs Float45.92M Perf Month4.41%
Income21.70M PEG1.48 EPS next Q0.15 Inst Own67.10% Short Float9.98% Perf Quarter28.66%
Sales126.10M P/S3.43 EPS this Y25.00% Inst Trans15.53% Short Ratio7.19 Perf Half Y69.58%
Book/sh3.14 P/B2.72 EPS next Y25.00% ROA12.10% Target Price9.00 Perf Year77.34%
Cash/sh1.91 P/C4.47 EPS next 5Y14.10% ROE14.20% 52W Range4.24 - 8.89 Perf YTD69.25%
Dividend- P/FCF19.00 EPS past 5Y25.50% ROI5.60% 52W High-4.05% Beta2.15
Dividend %- Quick Ratio5.10 Sales past 5Y18.60% Gross Margin82.90% 52W Low101.18% ATR0.35
Employees570 Current Ratio5.60 Sales Q/Q-2.60% Oper. Margin19.30% RSI (14)60.24 Volatility3.23% 4.53%
OptionableYes Debt/Eq0.00 EPS Q/Q-6.30% Profit Margin17.10% Rel Volume0.63 Prev Close8.47
ShortableYes LT Debt/Eq0.00 EarningsNov 10 AMC Payout0.00% Avg Volume637.28K Price8.53
Recom2.50 SMA204.29% SMA5011.90% SMA20047.54% Volume399,698 Change0.71%
Nov-14-14Downgrade BWS Financial Buy → Hold $8.25 → $8
Nov-12-13Reiterated Aegis Capital Buy $9 → $8
Jul-16-13Upgrade Aegis Capital Hold → Buy $9
Sep-18-12Upgrade BWS Financial Hold → Buy $8.25
Aug-10-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
Apr-09-10Upgrade BWS Financial Hold → Buy $7.25
Jul-08-09Downgrade BWS Financial Buy → Hold $3.25
Jun-03-09Initiated ThinkEquity Buy $5
May-21-09Initiated Rodman & Renshaw Mkt Outperform $5
Sep-05-08Initiated Susquehanna Financial Neutral
Nov-18-14 01:04PM  SCICLONE PHARMACEUTICALS INC Financials EDGAR Online Financials
Nov-14-14 12:19PM  SciClone Pharma downgraded by BWS Financial Briefing.com
Nov-12-14 07:09PM  10-Q for SciClone Pharmaceuticals, Inc. Company Spotlight +5.22%
Nov-10-14 04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN +5.06%
04:08PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  SciClone Reports Financial Results for the Third Quarter 2014 Marketwired
07:07AM  Q3 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Nov-06-14 06:00AM  SciClone to Present at Jefferies Global Healthcare Conference on November 19th Marketwired
Nov-03-14 12:34PM  Story Stocks from Briefing.com Briefing.com
Oct-30-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th Marketwired
Sep-17-14 06:00AM  SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014 Marketwired
Sep-03-14 06:00AM  SciClone to Present at Aegis 2014 Healthcare & Technology Conference on September 11, 2014 Marketwired
Aug-28-14 11:17AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02:00AM  SciClone and BTG Announce That DC Bead(R) Has Been Approved by China Food and Drug Administration Marketwired
Aug-11-14 04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
04:05PM  SciClone Reports Financial Results for the Second Quarter 2014 Marketwired
07:07AM  Q2 2014 SciClone Pharmaceuticals Inc Earnings Release - After Market Close CCBN
Jul-31-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Second Quarter 2014 on August 11th Marketwired
Jun-13-14 12:05PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Jun-11-14 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); $5.50 Price Target Marketwired
May-27-14 06:00AM  SciClone to Present at Jefferies 2014 Global Healthcare Conference on June 3, 2014 Marketwired
May-12-14 11:59AM  SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha +6.28%
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  SciClone Pharmaceuticals (SCLN) Q4 2013 Results - Earnings Call Webcast at Seeking Alpha
07:07AM  Q1 2014 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:09AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:02AM  SciClone reports Q1 adjusted EPS 10c, one estimate 8c at theflyonthewall.com
06:00AM  SciClone Reports Financial Results for the First Quarter 2014 Marketwired
May-05-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the First Quarter 2014 on May 12th Marketwired
Apr-23-14 06:00AM  SciClone Pharmaceuticals Selects rfXcel to Meet China Product Compliance and Anti-Counterfeiting Goal Business Wire
Apr-01-14 06:00AM  SciClone to Present at Needham Healthcare Conference on April 8, 2014 Marketwired
Mar-18-14 09:00AM  Vista Partners Initiates Coverage on Soligenix, Inc. (Ticker: SNGX); $5.50 Price Target Marketwired
Mar-17-14 04:52PM  SciClone Reserves $2 Million For FCPA Settlement at The Wall Street Journal
03:33PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online
Mar-12-14 01:15PM  SciClone Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30AM   Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
07:07AM  Q4 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:12AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Reports 2013 Financial Results and 2014 Outlook Marketwired
Mar-03-14 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Fourth Quarter and Full Year 2013 on March 12th Marketwired
Feb-14-14 02:23PM  People Moves: Milbank, MoneyGram, SciClone, SEC at The Wall Street Journal
Feb-10-14 06:00AM  SciClone Appoints Charles Meng as General Counsel and Vice President of Compliance Marketwired
Feb-03-14 06:00AM  SciClone to Present at BIO CEO & Investor Conference on February 11, 2014 Marketwired
Jan-30-14 06:06PM  Nasdaq stocks posting largest percentage increases AP
Jan-27-14 10:15PM  Harwood Feffer LLP Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire -12.65%
04:30PM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of SciClone Pharmaceuticals, Inc. PR Newswire
10:08AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors SciClone Pharmaceuticals, Inc. PR Newswire
Jan-24-14 06:30PM  SciClone Announces Transition From Pricewaterhousecoopers LLP to Pricewaterhousecoopers Zhong Tian LLP as Independent Registered Public Accounting Firm Marketwired
05:57PM  SciClone says material weakness found in controls at theflyonthewall.com
05:02PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements EDGAR Online
Jan-16-14 02:15PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin EDGAR Online
Jan-15-14 07:00AM  4 Stocks Under $10 Moving Higher at TheStreet
Jan-09-14 11:59AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
06:00AM  SciClone Provides 2013 Financial Update and 2014 Guidance Marketwired
Jan-02-14 03:45PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online
Dec-02-13 06:00AM  SciClone to Present at Oppenheimer Healthcare Conference on December 10, 2013 Marketwired
Nov-14-13 04:16PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statement EDGAR Online
Nov-12-13 05:13PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online +7.16%
01:20PM  SciClone Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
08:30AM  SciClone Pharmaceuticals, Inc. Earnings Call scheduled for 8:30 am ET today CCBN
08:25AM  SciClone Pharmaceuticals, Inc. Discusses Q2 2013 Results (Webcast) at Seeking Alpha
07:07AM  Q3 2013 SciClone Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN
06:00AM  SciClone Reports Financial Results for the Three and Nine Months Ended September 30, 2013 Marketwired
Nov-05-13 06:00AM  SciClone Pharmaceuticals to Report Financial Results for the Third Quarter, 2013 on November 12th Marketwired
Sep-23-13 10:02AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and EDGAR Online
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for the treatment of oncology, infectious diseases, and cardiovascular disorders primarily in the People's Republic of China. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant, and as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, which include China, the Pacific Rim, Latin America, Eastern Europe, and the Middle East regions. The company markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. It also markets approximately 10 partnered products in China, including Aggrastat, an interventional cardiology product. The company holds license, promotion, distribution, or marketing agreements with various parties for products, including DC Bead, Abstral, Loramyc, and ondansetron RapidFilm. SciClone Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hawkins Richard JDirectorSep 29Option Exercise4.5550,000227,50050,000Oct 01 04:43 PM
CHANG NANCY TDirectorAug 15Buy6.0025,040150,22225,040Aug 19 06:54 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 14Option Exercise0.0012,500012,500Aug 18 02:53 PM
Zhao HongCEO, China OperationsMay 16Sale4.7512,50059,3750May 16 05:52 PM
Blobel FriedhelmPresident & CEOMay 14Option Exercise0.00182,0170232,053May 16 06:09 PM
Zhao HongCEO, China OperationsMay 14Option Exercise0.0012,500012,500May 16 05:52 PM
Blobel FriedhelmPresident & CEOFeb 28Buy3.951,0003,95350,036Mar 18 06:44 PM
Blobel FriedhelmPresident & CEONov 30Buy4.151,0004,14849,036Mar 18 06:44 PM